180
Views
10
CrossRef citations to date
0
Altmetric
Review

Is it safe to use topical NSAIDs for corneal sensitivity in Sjögren’s syndrome patients?

&
Pages 33-43 | Published online: 20 Dec 2006

Bibliography

  • FOX RI, STERN M, MICHELSON P: Update in Sjögren’s syndrome. Curr. Opin. Rheumatol. (2000) 12:391-398.
  • JONSSON R, HAGA HJ, GORDON TP: Current concepts on diagnosis, autoantibodies and therapy in Sjögren’s syndrome. Scand. J. Rheumatol. (2000) 29:341-348.
  • VITALI C, BOMBARDIERI S, JONSSON R et al.: Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann. Rheum. Dis. (2002) 61:554-558.
  • FOX RI, MICHELSON P: Approaches to the treatment of Sjögren’s syndrome. J. Rheumatol. (2000) 27(Suppl.):15-21.
  • ARAGONA P, ROMEO GF, OTERI F, GIORDANO G, SANTAMARIA S, FERRERI G: Correlazioni tra sensibilità corneale e funzione lacrimale in soggetti affetti da connettiviti. Boll. Ocul. (1994) 73(Suppl. 1):115-120.
  • ROSENBERG ME, TERVO TM, IMMONEN IJ, MULLER LJ, GRONHAGEN-RISKA C, VESALUOMA MH: Corneal structure and sensitivity in Type 1 diabetes mellitus. Invest. Ophthalmol. Vis. Sci. (2000) 41:2915-2921.
  • MULLER LJ, MARFURT CF, KRUSE F, TERVO TMT: Corneal nerves: structure, contents, and function. Exp. Eye Res. (2003) 76(5):521-542.
  • AVISAR R, ROBINSON A, APPEL I, YASSUR Y, WEINBERGER D: Diclofenac sodium, 0.1% (Voltaren Ophtha), versus sodium chloride, 5%, in the treatment of filamentary keratitis. Cornea (2000) 19(2):145-147.
  • AVUNDUK AM, AVUNDUK MC, VARNELL ED, KAUFMAN HE: The comparison of efficacies of topical corticosteroids and non-steroidal anti-inflammatory drops on dry eye patients: a clinical and immunocytochemical study. Am. J. Ophthalmol. (2003) 136:593-602.
  • FLACH AJ: Cyclo-oxygenase inhibitors in ophthalmology. Surv. Ophthalmol. (1992) 36(4):259-284.
  • GWON A, VAUGHAN ER, CHEETHAM JK, DE GRYSE R: Ocufen (flurbiprofen) in the treatment of ocular pain after radial keratotomy. CLAO J. (1994) 20(2):131-138.
  • ARSHINOFF S, D’ADDARIO D, SADLER C, BILOTTA R, JOHNSON TM: Use of topical non-steroidal antiinflammatory drugs in excimer laser photorefractive keratectomy. J. Cataract Refract. Surg. (1994) 20(Suppl.):216-222.
  • LOYA N, BASSAGE S, VYAS S, DEL CERRO M, PARK SB, AQUAVELLA JV: Topical diclofenac following excimer laser: effect on corneal sensitivity and wound healing in rabbits. J. Refract. Corneal Surg. (1994) 10(4):423-427.
  • SZERENYI K, SORKEN K, GARBUS J, LEE M, MCDONNELL PJ: Decrease in normal human corneal sensitivity with topical diclofenac sodium. Am. J. Ophthalmol. (1994) 118:312-315.
  • ZAIDMAN GW: Diclofenac and its effect on corneal sensation. Arch. Ophthalmol. (1995) 113(3):262.
  • ARAGONA P, TRIPODI G, SPINELLA R, LAGANÀ E, FERRERI G: The effects of the topical administration of non-steroidal anti-inflammatory drugs on corneal epithelium and corneal sensitivity in normal subjects. Eye (2000) 14:206-210.
  • ARAGONA P, STILO A, FERRERI F, MOBRICI M: Effects of the topical treatment with NSAIDs on corneal sensitivity and ocular surface of Sjögren’s syndrome patients. Eye (2005) 19(5):535-539.
  • MURPHY PJ, PATEL S, KONG N, RYDER REJ, MARSHALL J: Noninvasive assessment of corneal sensitivity in young and elderly diabetic and nondiabetic subjects. Invest. Ophthalmol. Vis. Sci. (2004) 45:1737-1742.
  • TERVO K, LATVALA TM, TERVO TMT: Recovery of corneal innervation following photorefractive keratoablation. Arch. Ophthalmol. (1994) 112:1466-1477.
  • UEDA S, DEL CERRO M, LACASCIO JA, AQUAVELLA JV: Peptidergic and catecholaminergic fibers in the human corneal epithelium. Acta Ophthalmol. (1989) 67(Suppl.):80-90.
  • AURAN JD, KOESTER CJ, KLEIMAN NJ et al.: Scanning slit confocal microscopic observation of cell morphology and movement within the normal human anterior cornea. Ophthalmology (1995) 102(1):33-41.
  • MACIVER MB, TANELIAN DL: Free nerve ending terminal morphology is fiber type specific for A-delta and C fibers innervating rabbit corneal epithelium. J. Neurophysiol. (1993) 69:1779-1783.
  • TANELIAN DL, BEUERMAN RW: Responses of rabbit corneal nociceptors to mechanical and thermal stimulation. Exp. Neurol. (1984) 84:165-178.
  • BELMONTE C, GARCIA-HIRSCHFELD J, GALLAR J: Neurobiology of ocular pain. Prog. Retin. Eye Res. (1997) 16:117-156.
  • GALLAR J, POZO MA, TUCKETT RP, BELMONTE C: Response of sensory units with unmyelinated fibres to mechanical, thermal and chemical stimulation of the cat’s cornea. J. Physiol. (1993) 468:609-622.
  • MULLER LJ, PELS L, VRENSEN GFJM: Ultrastructural organization of human corneal nerves. Invest. Ophthalmol. Vision Sci. (1996) 37:476-488.
  • MULLER LJ, VRENSEN GFJM, PELS L, NUNES CARDOZO B, WILLEKENS B: Architecture of human corneal nerves. Invest. Ophthalmol. Vis. Sci. (1997) 38:985-994.
  • BELMONTE C, GALLAR J, POZO MA, REBOLLO I: Excitation by irritant chemical substances of sensory afferent units in the cat’s cornea. J. Physiol. (1991) 437:709-725.
  • ACOSTA MC, BELMONTE C, GALLAR J: Sensory experiences in humans and single-unit activity in cats evoked by polymodal stimulation of the cornea. J. Physiol. (2001) 534(Pt. 2):511-525.
  • FENG Y, SIMPSON TL: Nociceptive sensation and sensitivity evoked from human cornea and conjunctiva stimulated by CO2. Invest. Ophthalmol. Vis. Sci. (2003) 44:529-532.
  • VAN BIJSTERVELD OP, KRUIZE AA, BLEYS RL: Central nervous system mechanisms in Sjögren’s syndrome. Br. J. Ophthalmol. (2003) 87:128-130.
  • ALPER MG: The anesthetic eye: an investigation of changes in the anterior ocular segment of the monkey caused by interrupting the trigeminal nerve at various levels along its course. Trans. Am. Ophthalmol. Soc. (1975) 73:313-365.
  • RECORDS RE: Eyebrows and eyelids (chapter 1). In: Biomedical Foundations of Ophthalmology (volume 2). Duane TD, Jaeger EA (Eds), Harper & Row, Philadelphia, USA (1987):17-20.
  • GALETTA S, MAY M: The facial nerve (chapter 8). In: Clinical Ophthalmology (volume 2). Duane TD, Jaeger EA (Eds), JB Lippincott, Philadelphia, USA (1989).
  • ONGERBOER DE VISSER BW, MOFFIE D: Effects of brain-stem and thalamic lesions on the corneal reflex: an electrophysiological and anatomical study. Brain (1979) 102:595-608.
  • HOLSTEGE G, KUYPERS HGJM: Propriobulbar fibre connections to trigeminal, facial and hypoglossal motor nuclei. I. An antero grade degeneration study in the cat. Brain (1977) 100:239-264.
  • HOLSTEGE G, KUYPERS HGJM, DEKKER JJ: The organization of the bulbar fibre connections to the trigeminal, facial and hypoglossal motor nuclei. II. An autoradiographic tracing study in cat. Brain (1977) 100:264-286.
  • MILLODOT M: The influence of age on the sensitivity of the cornea. Invest. Ophthalmol. Vis. Sci. (1977) 16:240-242.
  • RISS B, BINDER S, RISS P, KEMETER P: Corneal sensitivity during the menstrual cycle. Br. J. Ophthalmol. (1982) 66:123-126.
  • KODAMA T, HAYASAKA S, SETOGAWA T: Immunofluorescent staining and corneal sensitivity in patients suspected of having herpes simplex keratitis. Am. J. Ophthalmol. (1992) 113:187-189.
  • MCNAMARA NA, BRAND RJ, POLSE KA, BOURNE WM: Corneal function during normal and high serum glucose levels in diabetes. Invest. Ophthalmol. Vis. Sci. (1998) 39(1):3-17.
  • MARTIN XY, SAFRAN AB: Corneal hypoesthesia. Surv. Ophthalmol. (1988) 33(1):28-40.
  • MAGENDIE J: De la influenca de la cinquime paire nerfts surla nutrition et les functions de loeil. J. Physiol. (1824) 4:176.
  • BEUERMAN RW, SCHIMMELPFENNIG B: Sensory denervation of the rabbit cornea affects epithelial properties. Exp. Neurol. (1980) 69:196-201.
  • TERVO K, TERVO T, ERANKO L, VANNAS A, CUELLO AC, ERANKO O: Substance P-immunoreactive nerves in the human cornea and iris. Invest. Ophthalmol. Vis. Sci. (1982) 23:671-674.
  • LAMBIASE A, MANNI L, BONINI S, RAMA P, MICERA A, ALOE L: Nerve growth factor promotes corneal healing: structural, biochemical, and molecular analyses of rat and human corneas. Invest. Ophthalmol. Vis. Sci. (2000) 41:1063-1069.
  • GARCIA-HIRSCHFELD J, LOPEZ-BRIONES LG, BELMONTE C: Neurotrophic influences on corneal epithelial cells. Exp. Eye Res. (1994) 59:597-605.
  • GROOS EB: Neurotrophic keratitis. In: Cornea: Fundamentals of Corneal and External Disease. Krachmer JH (Ed.), Mosby, St. Louis, USA (1997):1339-1362.
  • MACKIE IA: Neuroparalytic keratitis. In: Current Ocular Therapy. 5th ed. Fraunfelder F, Roy FH (Eds), WB Saunders, Philadelphia, USA (2000) 369-371.
  • AKAKI K, OHASHI Y, KINOSHITA S, HAYASHI K, KUWAYMA Y, TANO Y: Epithelial wound healing in the denervated cornea. Curr. Eye Res. (1994) 13:203-211.
  • WILSON SE, AMBROSIO R: Laser in situ keratomileusis-induced neurotrophic epitheliopathy. Am. J. Ophthalmol. (2001) 132:405-406.
  • TUOMINEN ISJ, KONTTINEN YT, VESALUOMA MH, MOILANEN JAO, HELINTÖ M, TERVO TMT: Corneal innervation and morphology in primary Sjögren’s syndrome. Invest. Ophthalmol. Vis. Sci. (2003) 44:2545-2549.
  • ANDONOPOULOS AP, CHRISTODOULOU J, BALLAS C, BOUNAS A, ALEXOPOULOS D: Autonomic cardiovascular neuropathy in Sjögren’s syndrome. A controlled study. J. Rheumatol. (1998) 25:2385-2388.
  • KOVÁCS L, TÖRÖK T, BARI F et al.: Impaired microvascular response to cholinergic stimuli in primary Sjögren’s syndrome. Ann. Rheum. Dis. (2000) 59:48-53.
  • BARENDREGT PJ, TULEN JHM, VAN DEN MEIRACKER AH, MARKUSSE HM: Spectral analysis of heart rate and blood pressure variability in primary Sjögren’s syndrome. Ann. Rheum. Dis. (2000) 61:232-236.
  • BARENDREGT PJ, VAN DEN MEIRACKER AH, MARKUSSE HM et al.: Parasympathetic failure does not contribute to ocular dryness in primary Sjögren’s syndrome. Ann. Rheum. Dis. (1999) 58:746-750.
  • GREENSPAN JS, DANIELS TE, TALAL N, SYLVESTER RA: The histopathology of Sjögren’s syndrome in labial salivary gland biopsies. Oral Surg. Oral Med. Oral Pathol. (1974) 37:217-229.
  • ANDOH Y, SHIMURA S, SAWAI T, SASAKI H, TAKISHIMA T, SHIRATO K: Morphometric analysis of secretory glands in Sjögren’s syndrome. Am. Rev. Respir. Dis. (1993) 148:1358-1362.
  • LEROY JP, PENNEC YL, SOULIER C, BERTHELOT JM, LETOUX G, YOUINOU P: Follow up study of labial salivary gland lesions in primary Sjögren’s syndrome. Ann. Rheum. Dis. (1992) 51:777-780.
  • BARENDREGT PJ, VAN DEN BENT MJ, VAN RAAIJ-VAN DEN AARSSEN VJM et al.: Involvement of peripheral nervous system in primary Sjögren’s syndrome. Ann. Rheum. Dis. (2001) 60:876-881.
  • ARAGONA P, MACCHIA G, BECHERUCCI C et al.: Ruolo dell’interleuchina-1 nella patogenesi delle alterazioni della superficie oculare in pazienti con sindrome di Sjögren secondaria. Boll. Ocul. (1995) 74(Suppl. 1):323-330.
  • SOLOMON A, DURSUN D, LIU Z, XIE Y, MACRI A, PFLUGFELDER SC: Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease. Invest. Ophthalmol. Vis. Sci. (2001) 42(10):2283-2292.
  • TISHLER M, YARON I, GEYER O, SHIRAZI I, NAFTALIEV E, YARON M: Elevated tear interleukin-6 levels in patients with Sjögren syndrome. Ophthalmology (1998) 105(12):2327-2329.
  • OSHIDA T, IWATA M, SAKIMOTO T, SAWA M: Tumor necrosis factor-alpha in tears of patients with Sjögren syndrome. Nippon Ganka Gakkai Zasshi (2004) 108(5):297-301.
  • DICKENSEN AH: Spinal cord pharmacology of pain. Br. J. Anaesth. (1995) 75:193-200.
  • BARENDREGT PJ, VAN DE HEYDE GL, BREEDVELD FC et al.: Parasympathetic dysfunction in rheumatoid arthritis patients with ocular dryness. Ann. Rheum. Dis. (1996) 55:612-615.
  • MANDL T, BORNMYR SV, CASTENFORS J et al.: Sympathetic dysfunction in patients with primary Sjögren’s syndrome. J. Rheumatol. (2001) 28:296-301.
  • GEMIGNANI F, MARBINI A, PAVESI G et al.: Peripheral neuropathy associated with primary Sjögren’s syndrome. J. Neurol. Neurosurg. Psychiatry (1994) 57:983-986.
  • KAPLAN JG, ROSENBERG R, REINITZ E, BUCHBINDER S, SCHAUMBURG HH: Invited review: peripheral neuropathy in Sjögren’s syndrome. Muscle Nerve (1990) 13:570-579.
  • KALTREIDER HB, TALAL N: The neuropathy of Sjögren’s syndrome. Trigeminal nerve involvement. Ann. Intern. Med. (1969) 70:751-762.
  • XU KP, YAGI Y, TSUBOTA K: Decrease in corneal sensivity and change in tear function in dry eye. Cornea (1996) 15:235-239.
  • STERN ME, BUERMAN RW, FOX RI, GAO J, MIRCHEFF AK, PLUGFELDER SC: The pathology of dry eye: the interaction between the ocular surface and lacrimal glands. Cornea (1998) 17:584-589.
  • MILLODOT M: Objective measurement of corneal sensitivity. Acta Ophthalmol. (1973) 51:325-334.
  • BOBERG-ANS J: On the corneal sensitivity. Acta Ophthalmol. (1976) 34(Suppl.):149.
  • BELMONTE C, ACOSTA MC, SCHMELZ M, GALLAR J: Measurement of corneal sensitivity to mechanical and chemical stimulation with a CO2 esthesiometer. Invest. Ophthalmol. Vis. Sci. (1999) 40:513-519.
  • INSEL PA: Analgesic-antipyretics and antiinflammatory agents; drugs employed in the treatment of rheumatoid arthritis and gout. In: Goodman and Gilman’s The Pharmacological Basis of Therapeutics. VIII edn. Goodman Gilman A, Rall TW, Nies AS, Taylor P (Eds), Pergamon Press, New York, USA (1990):638-681.
  • BUCKLEY MM, BROGDEN RN: Ketorolac. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential. Drugs (1990) 39(1):86-109.
  • SUN R, GIMBEL HV: Effects of topical ketorolac and diclofenac on normal corneal sensation. J. Refract. Surg. (1997) 13(2):158-161.
  • SEITZ B, SORKEN K, LABREE LD, GARBUS JJ, MC DONNELL PJ: Corneal sensitivity and burning sensation. Arch. Ophthalmol. (1996) 114:921-924.
  • LAITINEN J, NUUTINEN L, KIISKILA EL et al.: Comparison of intravenous diclofenac, indomethacin and oxycodone as post-operative analgesics in patients undergoing knee surgery. Eur. J. Anaesth. (1992) 9:29-34.
  • BELLAMY N, BENSEN WG, FORD PM, HUANG SH, LANG JY: Double-blind randomized controlled trial of flurbiprofen-SR (ANSAID-SR) and diclofenac sodium-SR (Voltaren-SR) in the treatment of osteoarthritis. Clin. Invest. Med. (1992) 15(5):427-433.
  • TOSCANI F, PIVA L, CORLI O et al.: Ketorolac versus diclofenac sodium in cancer pain. Arzneimittelforschung (1994) 44(4):550-554.
  • TODD PA, SORKIN EM: Diclofenac sodium: a reappraisal of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy. Drugs (1988) 35:244-285.
  • MARTINI A, BONDIOLOTTI GP, SACERDOTE P et al.: Diclofenac increases beta-endorphins plasma concentrations. J. Int. Med. Res. (1984) 12:92-95.
  • RAINSFORD KD: The mode of action of azapropazone in relation to its therapeutic actions in rheumatic conditions and its major side-effects. In: Azapropazone: 20 years of clinical use. Rainsford KD (Ed.), Kluwer Academic Publishers, Lancaster, UK (1989):31-52.
  • CHEN X, GALLAR J, BELMONTE C: Reduction by anti-inflammatory drugs of the response of corneal sensory nerve fibers to chemical irritation. Invest. Ophthalmol. Vis. Sci. (1997) 38(10):1944-1953.
  • MCCORMACK K, BRUNE K: Dissociation between the antinociceptive and anti-inflammatory effects of the nonsteroidal anti-inflammatory drugs: a survey of their analgesic efficacy. Drugs (1991) 41(4):533-547.
  • TASSORELLI C, GRECO R, SANDRINI G, NAPPI G: Central components of the analgesic/antihyperalgesic effect of nimesulide: studies in animal models of pain and hyperalgesia. Drugs (2003) 63(Suppl. 1):9-22.
  • CAMU F, SHI L, VANLERSBERGHE C: The role of COX-2 inhibitors in pain modulation. Drugs (2003) 63(Suppl. 1):1-7.
  • ACOSTA MC, BERENGUER-RUIZ L, GARCIA-GALVEZ A, PEREA-TORTOSA D, GALLAR J, BELMONTE C: Changes in mechanical, chemical, and thermal sensitivity of the cornea after topical application of nonsteroidal anti-inflammatory drugs. Invest. Ophthalmol. Vis. Sci. (2005) 46(1):282-286.
  • PATRONE G, SACCÀ SC, MACRI A, ROLANDO M: Evaluation of the analgesic effect of 0.1% indomethacin solution on corneal abrasions. Ophthalmologica (1999) 213:350-354.
  • PHILLIPS AF, HAYASHI S, SEITZ B, WEE WR, MCDONNELL PJ: Effect of diclofenac, ketorolac, and fluorometholone on arachidonic acid metabolites following excimer laser corneal surgery. Arch. Ophthalmol. (1996) 114:1495-1498.
  • TOMAS-BARBERAN S, FAGERHOLM P: Influence of topical treatment on epithelial wound healing and pain in the early postoperative period following photorefractive keratectomy. Acta Ophthalmol. Scand. (1999) 77:135-138.
  • HSU JK, JOHNSTON WT, READ RW et al.: Histopathology of corneal melting associated with diclofenac use after refractive surgery. J. Cataract Refract. Surg. (2003) 29:250-256.
  • GUIDERA AC, LUCHS JI, UDELL IJ: Keratitis, ulceration, and perforation associated with topical nonsteroidal anti-inflammatory drugs. Ophthalmology (2001) 108:936-944.
  • SHER NA, FRANTZ JM, TALLEY A et al.: Topical diclofenac in the treatment of ocular pain after excimer photorefractive keratectomy. Refract. Cornea Surg. (1993) 9:425-436.
  • CONGDON NG, SCHEIN OD, VON KULAJTA P, LUBOMSKI LH, GILBERT D, KATZ J: Corneal complications associated with topical ophthalmic use of nonsteroidal antiinflammatory drugs. J. Cataract Refract. Surg. (2001) 27:622-631.
  • KUNERT KS, TISDALE AS, STERN ME, SMITH JA, GIPSON IK: Analysis of topical cyclosporine treatment of patients with dry eye syndrome: effect on conjunctival lymphocytes. Arch. Ophthalmol. (2000) 118:1489-1496.
  • FLACH AJ: Corneal melts associated with topically applied nonsteroidal anti-inflammatory drugs. Trans. Am. Ophthalmol. Soc. (2001) 99:205-210.
  • LIN JC, RAPUANO CJ, LAIBSON PR, EAGLE RC Jr, COHEN EJ: Corneal melting associated with use of topical nonsteroidal anti-inflammatory drugs after ocular surgery. Arch. Ophthalmol. (2000) 118:1129-1132.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.